Literature DB >> 21031415

Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR.

Tae-Jung Kim1, Youn Soo Lee, Jin-Hyung Kang, Yeon-Sil Kim, Chang Suk Kang.   

Abstract

BACKGROUND AND OBJECTIVES: This study evaluated several tumor angiogenesis-related markers to examine their expression pattern and relation to clinicopathologic implications of nasopharyngeal carcinoma.
METHODS: Paraffin sections from 69 nasopharyngeal carcinomas obtained before radiotherapy were prepared. The expression of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (Cox-2), C-erbB2, and epidermal growth factor receptor (EGFR) were investigated by immunohistochemistry and then correlated with various clinicopathologic parameters.
RESULTS: VEGF was inversely correlated with C-erbB2 (P = 0.036). In survival analysis, high mitosis (≥5/10 high power field) was significantly associated with worse relapse-free survival in univariate analysis (P = 0.048) but not in multivariate analysis (P = 0.153). High stage, high mitotic rate, absence of VEGF, and presence of Cox-2 were associated with worse survival in both univariate analysis (P = 0.002, P = 0.038, P = 0.044, and P = 0.028, respectively) and multivariate analysis (P = 0.007, P = 0.036, P = 0.047, and P = 0.004, respectively).
CONCLUSIONS: Absence of VEGF is a useful indicator of poor prognosis in addition to Cox-2 expression, high stage, and high mitosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21031415     DOI: 10.1002/jso.21767

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma.

Authors:  Warut Tulalamba; Noppadol Larbcharoensub; Ekaphop Sirachainan; Aunchalee Tantiwetrueangdet; Tavan Janvilisri
Journal:  Tumour Biol       Date:  2015-02-28

2.  Analysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancer.

Authors:  Pei Yang; Weiye Deng; Yaqian Han; Yingrui Shi; Ting Xu; Juan Shi; Hesham Elhalawani; Yu Zhao; Xiaoxue Xie; Fan Lou; Rong Zhang; Hekun Jin
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

3.  Overexpression of ERBB3 promotes proliferation, migration, and angiogenesis in nasopharyngeal carcinoma.

Authors:  Bingyue Duan; Ziyu Zhu; Bo You; Si Shi; Ying Shan; Pan Jiang; Qicheng Zhang; Lili Bao; Yong Yin; Yiwen You
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

4.  Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis.

Authors:  Bin Yang; Lin Jia; Qiaojuan Guo; Hui Ren; Yanping Hu; Tao Xie
Journal:  Oncotarget       Date:  2016-07-26

5.  A large-scale retrospective study of the overall survival outcome in nasopharyngeal carcinoma with hypertension in Chinese population.

Authors:  Pei Yang; Hesham Elhalawani; Yingrui Shi; Ying Tang; Yaqian Han; Yu Zhao; Fan Lou; Hekun Jin
Journal:  Oncotarget       Date:  2017-04-27

6.  Cyclooxygenase-2 Expression and Its Correlation with Primary Tumor Size and Lymph Node Involvement in Nasopharyngeal Carcinoma.

Authors:  Jessy Chrestella; Farhat Farhat; Elvita Rahmi Daulay; Rizalina Arwinati Asnir; Ashri Yudhistira; Indah Afriani Nasution
Journal:  Open Access Maced J Med Sci       Date:  2018-11-19

7.  A Meta-Analysis of Vascular Endothelial Growth Factor for Nasopharyngeal Cancer Prognosis.

Authors:  Feng Wang; Lisha Peng; Yong Wang; Xiaodong Liu
Journal:  Front Oncol       Date:  2018-10-31       Impact factor: 6.244

Review 8.  Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis.

Authors:  Ellen Frejborg; Tuula Salo; Abdelhakim Salem
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

9.  LncRNA GAS5/miR‑4465 axis regulates the malignant potential of nasopharyngeal carcinoma by targeting COX2.

Authors:  Qiong Zhong; Zongqi Wang; Xiaohong Liao; Renrui Wu; Xiaoqing Guo
Journal:  Cell Cycle       Date:  2020-10-23       Impact factor: 4.534

10.  Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer.

Authors:  Foteinos-Ioannis Dimitrakopoulos; Georgia-Angeliki Koliou; Vassiliki Kotoula; Kyriaki Papadopoulou; Konstantinos Markou; Konstantinos Vlachtsis; Nikolaos Angouridakis; Ilias Karasmanis; Angelos Nikolaou; Amanda Psyrri; Anastasios Visvikis; Paris Kosmidis; George Fountzilas; Angelos Koutras
Journal:  Cancers (Basel)       Date:  2021-03-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.